The subgroup analysis of types of severe complications revealed that studies that enrolled patients with cerebral and noncerebral severe malaria demonstrated lower mean IL-4 levels than patients with uncomplicated malaria (pooled MD −5.91 pg/mL, 95% CI −9.15 to −2.67) pg/mL, I2 99.07%, five studies). This evidence concerns the gene IL4 and malaria.